Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper provides consensus recommendations on the management of cutaneous basal cell carcinoma and squamous cell carcinoma in the head and neck region on the basis of current evidence. Recommendations: • Royal College of Pathologists minimum datasets for NMSC should be adhered to in order to improve patient care and help work-force planning in pathology departments. (G) • Tumour depth is of critical importance in identifying high-risk cutaneous squamous cell carcinoma (cSCC), and should be reported in all cases. (R) • Appropriate imaging to determine the extent of primary NMSC is indicated when peri-neural involvement or bony invasion is suspected. (R) • In the clinically N0 neck, radiological imaging is not beneficial, and a policy of watchful waiting and patient education can be adopted. (R) • Patients with high-risk NMSC should be treated by members of a skin cancer multidisciplinary team (MDT) in secondary care. (G) • Non-infiltrative basal cell carcinoma (BCC) <2 cm in size should be excised with a margin of 4–5 mm. Smaller margins (2–3 mm) may be taken in sites where reconstructive options are limited, when reconstruction should be delayed. (R) • Where there is a high risk of recurrence, delayed reconstruction or Mohs micrographic surgery should be used. (R) • Surgical excision of low-risk cSCC with a margin of 4 mm or greater is the treatment of choice. (R) • High-risk cSCC should be excised with a margin of 6 mm or greater. (R). • Mohs micrographic surgery has a role in some high-risk cSCC cases following MDT discussion. (R) • Delayed reconstruction should be used in high-risk cSCC. (G) • Intra-operative conventional frozen section in cSCC is not recommended. (G) • Radiotherapy (RT) is an effective therapy for primary BCC and cSCC. (R) • Re-excision should be carried out for incompletely excised high-risk BCC or where there is deep margin involvement. (R) • Incompletely excised high-risk cSCC should be re-excised. (R) • Further surgery should involve confirmed marginal clearance before reconstruction. (R) • P+ N0 disease: Resection should include involved parotid tissue, combined with levels I–III neck dissection, to include the external jugular node. (R) • P+ N+ disease: Resection should include level V if that level is clinically or radiologically involved. (R) • Adjuvant RT should include level V if not dissected. (R) • P0 N+ disease: Anterior neck disease should be managed with levels I–IV neck dissection to include the external jugular node. (R) • P0 N+ posterior echelon nodal disease (i.e. occipital or post-auricular) should undergo dissection of levels II–V, with sparing of level I. (R) • Consider treatment of the ipsilateral parotid if the primary site is the anterior scalp, temple or forehead. (R) • All patients should receive education in self-examination and skin cancer prevention measures. (G) • Patients who have had a single completely excised BCC or low-risk cSCC can be discharged after a single post-operative visit. (G) • Patients with an excised high-risk cSCC should be reviewed three to six monthly for two years, with further annual review depending upon clinical risk. (G) • Those with recurrent or multiple BCCs should be offered annual review. (G)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Guidelines for the management of basal cell carcinoma
Telfer, N. R., Colver, G. B., & Morton, C. A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08666.x · Cited by 960
Schmults, C. D., Karia, P. S., Carter, J. B., Han, J., & Qureshi, A. A. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.2139 · Cited by 571
Karia, P. S., Jambusaria-Pahlajani, A., Harrington, D. P., Murphy, G. F., Qureshi, A. A., & Schmults, C. D. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5326 · Cited by 371
Interventions for basal cell carcinoma of the skin
Bath-Hextall, F. J., Perkins, W., Bong, J., & Williams, H. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003412.pub2 · Cited by 357
Veness, M. J., Morgan, G. J., Palme, C. E., & Gebski, V. (2005) · The Laryngoscope · doi:10.1097/01.mlg.0000158349.64337.ed · Cited by 295
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck
Mendenhall, W. M., Amdur, R. J., Hinerman, R. W., Cognetta, A. B., & Mendenhall, N. P. (2009) · The Laryngoscope · doi:10.1002/lary.20608 · Cited by 167
Cutaneous head and neck SCCs and risk of nodal metastasis – UK experience
Mourouzis, C., Boynton, A., Grant, J., Umar, T., Wilson, A., Macpheson, D., & Pratt, C. (2009) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2009.07.007 · Cited by 167
Zagrodnik, B., Kempf, W., Seifert, B., Müller, B., Burg, G., Urosevic, M., & Dummer, R. (2003) · Cancer · doi:10.1002/cncr.11798 · Cited by 142
Gurney, B., & Newlands, C. (2014) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2014.01.015 · Cited by 64
Self-citationStaged operations for basal cell carcinoma of the face
Niederhagen, B., von Lindern, J. J., Bergé, S. J., Appel, T., Reich, R. H., & Krüger, E. (2000) · British Journal of Oral and Maxillofacial Surgery · doi:10.1054/bjom.2000.0322 · Cited by 26
Cited by
Peris, K., Fargnoli, M. C., Garbe, C., Kaufmann, R., Bastholt, L., Seguin, N. B., Bataille, V., Marmol, V. D., Dummer, R., Harwood, C. A., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.06.003 · Cited by 599
Lebbe, C., Becker, J. C., Grob, J.-J., Malvehy, J., del Marmol, V., Pehamberger, H., Peris, K., Saiag, P., Middleton, M. R., Bastholt, L., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.131 · Cited by 500
Stratigos, A. J., Garbe, C., Dessinioti, C., Lebbe, C., Bataille, V., Bastholt, L., Dreno, B., Concetta Fargnoli, M., Forsea, A. M., Frenard, C., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.01.008 · Cited by 319
Stratigos, A. J., Garbe, C., Dessinioti, C., Lebbe, C., Bataille, V., Bastholt, L., Dreno, B., Fargnoli, M. C., Forsea, A. M., Frenard, C., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.01.007 · Cited by 242
“2019) [2], the American Academy of Dermatology (AAD) guidelines (2018) (based on the NCCN risk stratification) [3] and the United Kingdom National Multidisciplinary Guidelines for non-melanoma skin cancer [4].”
Background
Metadata
- Authors
- Newlands, C., Currie, R., Memon, A., Whitaker, S., & Woolford, T.
- Venue
- The Journal of Laryngology & Otology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2016-05
- Volume
- 130
- Issue
- S2
- Pages
- S125-S132
- ISSN
- 0022-2151 (ISSN-L)
- 1748-5460
- OpenAlex
- W2357949308
- Cited by
- 200
- References
- 12
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.